Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fenoldopam mesylate
Drug ID BADD_D00876
Description A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Indications and Usage For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.
Marketing Status approved
ATC Code C01CA19
DrugBank ID DB00800
KEGG ID D00613
MeSH ID D018818
PubChem ID 49659
TTD Drug ID D0R6BI
NDC Product Code 0409-3373; 50384-0130
UNII HA3R0MY016
Synonyms Fenoldopam | Fenoldopam Hydrobromide | Hydrobromide, Fenoldopam | SK&F-82526 | SK&F 82526 | SK&F82526 | SKF-82526 | SKF 82526 | SKF82526 | SKF-82526J | SKF 82526J | SKF82526J | SK&F-82526J | SK&F 82526J | SK&F82526J | Corlopam | Fenoldopam Mesylate
Chemical Information
Molecular Formula C17H20ClNO6S
CAS Registry Number 67227-57-0
SMILES CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Angina pectoris02.02.02.002; 24.04.04.002--
Anxiety19.06.02.002--
Back pain15.03.04.005--
Blood creatinine increased13.13.01.004--
Blood glucose increased13.02.02.002---
Blood lactate dehydrogenase increased13.04.02.002--
Blood urea increased13.13.01.006---
Bradycardia02.03.02.002---
Cardiac failure02.05.01.001--
Chest pain02.02.02.011; 08.01.08.002; 22.12.02.003---
Constipation07.02.02.001--
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dyspnoea02.11.05.003; 22.02.01.004--
Extrasystoles02.03.02.003---
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Headache17.14.01.001--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypokalaemia14.05.03.002--
Hypotension24.06.03.002--
Injection site reaction08.02.03.014; 12.07.03.015--
Insomnia17.15.03.002; 19.02.01.002--
Leukocytosis01.02.01.002--
Muscle spasms15.05.03.004--
Myocardial infarction02.02.02.007; 24.04.04.009--
Myocardial ischaemia02.02.02.008; 24.04.04.010---
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
The 1th Page    1 2    Next   Last    Total 2 Pages